Opus Genetics (IRD) Short Interest Ratio & Short Volume $4.44 +0.18 (+4.23%) Closing price 04:00 PM EasternExtended Trading$4.38 -0.06 (-1.35%) As of 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Opus Genetics Short Interest OverviewAs of April 30, 2026, Opus Genetics (IRD) had a short interest of 2.00 million shares sold short, representing 3.17% of the public float. This marks a 10.65% increase in short interest since the prior report. The short interest ratio (days to cover) is 2.2, meaning it would take 2.2 days of the average trading volume of 1.03 million shares to cover all short positions.Current Short Interest1,999,457 sharesPrevious Short Interest1,807,078 sharesChange Vs. Previous Month10.65%Dollar Volume Sold Short$10.22 millionShort Interest Ratio2.2 Days to CoverLast Record DateApril 30, 2026Outstanding Shares81,400,000 sharesShort Percent of Float3.17%Today's Trading Volume540,639 sharesAverage Trading Volume1,026,177 sharesToday's Volume Vs. Average53% Short Selling Opus Genetics? Sign up to receive the latest short interest report for Opus Genetics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIRD Short Interest Over TimeIRD Days to Cover Over TimeIRD Percentage of Float Shorted Over Time Opus Genetics Tesla Short Interest History & Recent Changes ExportReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20261,999,457 shares $10.22 million +10.7%3.2%2.16 $5.11 4/15/20261,807,078 shares $10.32 million -2.1%2.9%2.75 $5.71 3/31/20261,846,316 shares $8.40 million -8.3%2.9%2.75 $4.55 3/13/20262,014,121 shares $10.13 million +81.3%3.0%1.52 $5.03 2/27/20261,110,696 shares $4.62 million +17.9%1.7%1.25 $4.16 2/13/2026942,054 shares $3.43 million +41.8%1.5%0.72 $3.64 1/30/2026664,201 shares $1.53 million -30.7%1.0%0.72 $2.31 1/15/2026957,806 shares $1.99 million +31.5%1.5%2.07 $2.08 12/31/2025728,362 shares $1.46 million +14.5%1.1%2.48 $2.01 12/15/2025635,920 shares $1.35 million +9.4%1.0%0.85 $2.13 11/28/2025581,546 shares $1.23 million +50.5%0.9%1.56 $2.12 11/14/2025386,397 shares $726.43 thousand -22.6%0.7%0.64 $1.88 10/31/2025499,215 shares $1.15 million +61.6%0.9%1.04 $2.30 10/15/2025309,000 shares $618 thousand +145.8%1.2%1 $2.00 9/30/2025125,700 shares $207.41 thousand +39.5%0.6%0.4 $1.65 9/15/202590,100 shares $123.44 thousand +66.2%0.4%0.2 $1.37 8/31/202554,200 shares $66.12 thousand No Change0.2%0.1 $1.22 IRD Short Interest - Frequently Asked Questions What is Opus Genetics' current short interest? Short interest is the volume of Opus Genetics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,999,457 shares of IRD short. 3.17% of Opus Genetics' shares are currently sold short. Learn More on Opus Genetics' current short interest. What is a good short interest ratio for Opus Genetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IRD shares currently have a short interest ratio of 2.2. Learn More on Opus Genetics's short interest ratio. What is a good short interest percentage for Opus Genetics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.17% of Opus Genetics' floating shares are currently sold short. Is Opus Genetics' short interest increasing or decreasing? Opus Genetics saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,999,457 shares, an increase of 10.6% from the previous total of 1,807,078 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Opus Genetics' short interest compare to its competitors? 3.17% of Opus Genetics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Opus Genetics: Harrow, Inc. (19.93%), KalVista Pharmaceuticals, Inc. (30.93%), Biohaven Ltd. (19.16%), WAVE Life Sciences Ltd. (11.48%), MoonLake Immunotherapeutics (10.02%), ArriVent BioPharma, Inc. (16.77%), Corvus Pharmaceuticals, Inc. (27.23%), GH Research PLC (3.46%), Olema Pharmaceuticals, Inc. (17.08%), Maplight Therapeutics, Inc. (4.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks. What does it mean to sell short Opus Genetics stock? Short selling IRD is an investing strategy that aims to generate trading profit from Opus Genetics as its price is falling. IRD shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Opus Genetics? A short squeeze for Opus Genetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IRD, which in turn drives the price of the stock up even further. How often is Opus Genetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IRD, twice per month. The most recent reporting period available is April, 30 2026. What do IRD's short interest metrics mean? Understanding short interest metrics can help you assess how traders are positioning around a stock like IRD:Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity. More Short Interest Resources from MarketBeat Related Companies Harrow Short Interest KalVista Pharmaceuticals Short Interest Biohaven Short Interest WAVE Life Sciences Short Interest MoonLake Immunotherapeutics Short Interest ArriVent BioPharma Short Interest Corvus Pharmaceuticals Short Interest GH Research Short Interest Olema Pharmaceuticals Short Interest Maplight Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IRD) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersForget SpaceX. Buy the company Musk can't replace.The SpaceX IPO is expected to price at $1.75 trillion - and retail investors won't get an allocation. Banks an...Behind the Markets | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThis same-day trade is getting a lot of attentionZero-days-to-expiration trades happen every single day - and most traders either ignore them or use them wrong...Base Camp Trading | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThe filing was one thing. June 1 is another.The SpaceX filing got attention - but according to macroeconomic strategist Dr. Mark Skousen of The Oxford Clu...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opus Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opus Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
